Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

Journal of NeuroVirology

Volumn 19, Issue 2, 2013, Pages 150-156

  Morgan, E E ^a,h   Woods, S P ^a   Letendre, S L ^a   Franklin, D R ^a   Bloss, C ^c   Goate, A ^b   Heaton, R K ^a   Collier, A C ^d   Marra, C M ^d   Gelman, B B ^e   McArthur, J C ^f   Morgello, S ^g   Simpson, D M ^g   McCutchan, J A ^a   Ellis, R J ^a   Abramson, I ^a   Gamst, A ^a   Fennema Notestine, C ^a   Smith, D M ^a   Grant, I ^a   Vaida, F ^a   Clifford, D B ^b   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Genetics; HIV AIDS; Neuropsychological assessment

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APOLIPOPROTEIN E4; CELL DNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; GROUPS BY AGE; HETEROZYGOTE; HIGH RISK POPULATION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SUBSTANCE ABUSE; VIRUS LOAD;

ADULT; AGE FACTORS; AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOLIPOPROTEIN E4; ASYMPTOMATIC DISEASES; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; GENE DOSAGE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84882603994     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0152-3     Document Type: Article

References (40)

1. Achim CL, Adame A, Dumaop W, Everall IP, Masliah E (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 4:190-199
2. Antinori A, Arendt G, Becker JT et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799
3. Becker JT, Lopez OL, Dew MA, Aizenstein HJ (2004) Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 18(Suppl 1):S11-S18
4. Benedict RH (1997) Brief visuospatial memory test - revised. Psychological Assessment Resources, Odessa
5. Benedict RH, Schretlen D, Groninger L, Brandt J (1998) Hopkins verbal learning test - revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 12:43-55
6. Benton AL, Hamsher K, Sivan AB (1983) Multilingual aphasia examination. AJA Associates, Iowa City
7. Burt TD, Agan BK, Marconi VC et al (2008) Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A 105:8718-8723
8. Clifford DB, Fagan AM, Holtzman DM et al (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73:1982-1987
9. Corder EH, Robertson K, Lannfelt L et al (1998) HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4:1182-1184
10. Diehr MC, Heaton RK, Miller W, Grant I (1998) The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity. Assessment 5:375-387
11. Dunlop O, Goplen AK, Liestol K et al (1997) HIV dementia and apolipoprotein E. Acta Neurol Scand 95:315-318
12. Enoch MA, Shen PH, Xu K, Hodgkinson C, Goldman D (2006) Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol 20:19-26
13. Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK (1999) Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment 6:147-178
14. Golden CJ (1998) Stroop Color and Word Test. Stoelting, Chicago
15. Gronwall DM (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44:367-373
16. Heaton RK, Taylor M, Manly JJ (2002) Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In: Tulsky D, Saklofske D, Heaton RK, Chelune G, Ivnik R, Bornstein RA, Prifitera A, Ledbetter M (eds) Clinical interpretation of the WAIS-III and WMS-III. Academic, San Diego, pp 183-210
17. Heaton RK, Marcotte TD, Mindt MR et al (2004a) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317-331
18. Heaton RK, Miller SW, Taylor MJ, Grant I (2004b) Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Lutz
19. Heaton RK, Clifford DB, Franklin DR Jr et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-2096
20. Heaton RK, Franklin DR, Ellis RJ et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
21. Joska JA, Combrinck M, Valcour VG et al (2010) Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa. J Neurovirol 16:377-383
22. Kløve H (1963) Grooved pegboard. Lafayette Instruments, Lafayette
23. Kongs SK, Thompson LL, Iverson GL, Heaton RK (2000) Wisconsin Card Sorting Test - 64 Card Computerized Version. Psychological Assessment Resources, Odessa
24. Kuhlmann I, Minihane AM, Huebbe P, Nebel A, Rimbach G (2010) Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis 9:8
25. Magalhaes MG, Greenberg B, Hansen H, Glick M (2007) Comorbidities in older patients with HIV: a retrospective study. J Am Dent Assoc 138:1468-1475
26. Norman MA, Moore DJ, Taylor M et al (2011) Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test - Revised, Brief Visuospatial Memory Test - Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64 - Card Version. J Clin Exp Neuropsychol 33:793-804
27. Pemberton LA, Stone E, Price P, van Bockxmeer F, Brew BJ (2008) The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia. HIV Med 9:677-680
28. Psychological Corporation (1997) WAIS-III and WMS-III technical manual. Psychological Corporation, San Antonio
29. Rabinovici GD, Jagust WJ (2009) Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behav Neurol 21:117-128
30. Reitan RM, Wolfson D (1993) The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Neuropsychology, Tucson
31. Spector SA, Singh KK, Gupta S et al (2010) APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS 24:1471-1479
32. Tang MX, Stern Y, Marder K et al (1998) The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 279:751-755
33. Urosevic N, Martins RN (2008) Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 13:421-435
34. Valcour V, Shikuma C, Shiramizu B et al (2004) Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii aging with HIV cohort. J Neuroimmunol 157:197-202
35. Valcour V, Shiramizu B, Shikuma C (2008) Frequency of apolipoprotein E4 among older compared with younger HIV patients: support for detrimental effect of E4 on survival. Proc Natl Acad Sci U S A 105:E66, author reply E67-68
36. Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10:241-252
37. Vivithanaporn P, Heo G, Gamble J et al (2010) Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 75:1150-1158
38. WHO (1998) Composite international diagnostic interview. World Health Organization, Geneva
39. Woods SP, Rippeth JD, Frol AB et al (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26:759-778
40. Woods SP, Dawson MS, Weber E, Grant I (2010) The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol 32:398-407